Refine
Year of publication
Document Type
- Article (32)
- Book (5)
- Part of a Book (2)
- Preprint (2)
- Conference Proceeding (1)
- Part of Periodical (1)
Has Fulltext
- yes (43)
Is part of the Bibliography
- no (43)
Keywords
- Acute myeloid leukemia (4)
- AML (3)
- Begriff (3)
- Metapher (3)
- Bail-out <Wirtschaft> (2)
- Begriffsgeschichte <Fach> (2)
- Chemotherapy (2)
- Diagnostik (2)
- Experimental nuclear physics (2)
- Experimental particle physics (2)
- Früherkennung (2)
- Geschichte (2)
- Induction chemotherapy (2)
- Mammakarzinom (2)
- Nachsorge (2)
- Rettungsschirm (2)
- Richtlinie (2)
- Survival (2)
- breast cancer (2)
- diagnosis (2)
- follow‑up (2)
- guideline (2)
- screening (2)
- All-trans retinoic acid (1)
- Allograft bone block (1)
- Antibiotic steward-ship (1)
- Antibiotics (1)
- Autogenous bone block (1)
- Bone marrow (1)
- Bone marrow aspiration (1)
- CBC (1)
- CDI (1)
- Cancer chemotherapy (1)
- Capnography (1)
- Colorectal cancer (1)
- Cytogenetics (1)
- Death rates (1)
- Deletion mutation (1)
- ESBL (1)
- Early goal-directed therapy (1)
- Endoscopy (1)
- Enterobacteriaceae (1)
- Evidence-based guidelines (1)
- Fevers (1)
- Fluid overload (1)
- Hepatocellular carcinoma (1)
- Hospitals (1)
- Hypoxia (1)
- Infection (1)
- Integrated Pulmonary Index (1)
- Intensive care treatment (1)
- Intensive care unit (1)
- Inverse kinematics (1)
- Isoscalar giant resonances (1)
- JAWSTAT pathway (1)
- Karyotypes (1)
- Liver cancer (1)
- Liver cirrhosis (1)
- Long term result (1)
- Massendaten (1)
- Methicillin-resistant Staphylococcus aureus (1)
- Monitoring (1)
- Mortality (1)
- Multidrug-resistant organisms (1)
- Netz (1)
- Netzwerk (1)
- Neutropenia (1)
- Nucleophosmin-1 (1)
- Percutaneous endoscopic gastrostomy (1)
- Peripheral blood smears (1)
- Pink esthetic score (1)
- Psoriasis vulgaris (1)
- QA/QC (1)
- Relapse surveillance (1)
- STAT3 (1)
- Semantik (1)
- Sepsis-bundle (1)
- Storage ring (1)
- Treatment (1)
- VRE (1)
- Vacuoles (1)
- Vernetzung (1)
- aging (1)
- ambulatory assessment (1)
- axions (1)
- biliary stricture (1)
- bleeding (1)
- breast (1)
- cell proliferation (1)
- context (1)
- dark matter experiments (1)
- education (1)
- experience sampling (1)
- induction chemotherapy (1)
- intracranial hemorrhage (1)
- liver transplantation (1)
- mechanical accuracy (1)
- multidrug resistance (1)
- phantom study (1)
- platelet substitution (1)
- real-life study (1)
- recurrent cholangitis (1)
- robot-guided stereotaxy (1)
- short-course antibiotic therapy (1)
- situation (1)
- solar physics (1)
- stereotactic frame (1)
- stereotactic neurosurgery (1)
- training (1)
- white and brown dwarfs (1)
- xenograft (1)
Institute
- Medizin (23)
- Physik (7)
- Frankfurt Institute for Advanced Studies (FIAS) (5)
- Informatik (2)
- Informatik und Mathematik (2)
- ELEMENTS (1)
- Erziehungswissenschaften (1)
- Extern (1)
- Georg-Speyer-Haus (1)
Patients with acute myeloid leukemia (AML) are often exposed to broad-spectrum antibiotics and thus at high risk of Clostridioides difficile infections (CDI). As bacterial infections are a common cause for treatment-related mortality in these patients, we conducted a retrospective study to analyze the incidence of CDI and to evaluate risk factors for CDI in a large uniformly treated AML cohort. A total of 415 AML patients undergoing intensive induction chemotherapy between 2007 and 2019 were included in this retrospective analysis. Patients presenting with diarrhea and positive stool testing for toxin-producing Clostridioides difficile were defined to have CDI. CDI was diagnosed in 37 (8.9%) of 415 AML patients with decreasing CDI rates between 2013 and 2019 versus 2007 to 2012. Days with fever, exposition to carbapenems, and glycopeptides were significantly associated with CDI in AML patients. Clinical endpoints such as length of hospital stay, admission to ICU, response rates, and survival were not adversely affected. We identified febrile episodes and exposition to carbapenems and glycopeptides as risk factors for CDI in AML patients undergoing induction chemotherapy, thereby highlighting the importance of interdisciplinary antibiotic stewardship programs guiding treatment strategies in AML patients with infectious complications to carefully balance risks and benefits of anti-infective agents.
Purpose: The aim of this official guideline coordinated and published by the German Society for Gynecology and Obstetrics (DGGG) and the German Cancer Society (DKG) was to optimize the screening, diagnosis, therapy and follow-up care of breast cancer.
Methods: The process of updating the S3 guideline dating from 2012 was based on the adaptation of identified source guidelines which were combined with reviews of evidence compiled using PICO (Patients/Interventions/Control/Outcome) questions and the results of a systematic search of literature databases and the selection and evaluation of the identified literature. The interdisciplinary working groups took the identified materials as their starting point to develop recommendations and statements which were modified and graded in a structured consensus procedure.
Recommendations: Part 1 of this short version of the guideline presents recommendations for the screening, diagnosis and follow-up care of breast cancer. The importance of mammography for screening is confirmed in this updated version of the guideline and forms the basis for all screening. In addition to the conventional methods used to diagnose breast cancer, computed tomography (CT) is recommended for staging in women with a higher risk of recurrence. The follow-up concept includes suggested intervals between physical, ultrasound and mammography examinations, additional high-tech diagnostic procedures, and the determination of tumor markers for the evaluation of metastatic disease.
Ziele: Das Ziel dieser offiziellen Leitlinie, die von der Deutschen Gesellschaft für Gynäkologie und Geburtshilfe (DGGG) und der Deutschen Krebsgesellschaft (DKG) publiziert und koordiniert wurde, ist es, die Früherkennung, Diagnostik, Therapie und Nachsorge des Mammakarzinoms zu optimieren.
Methoden: Der Aktualisierungsprozess der S3-Leitlinie aus 2012 basierte zum einen auf der Adaptation identifizierter Quellleitlinien und zum anderen auf Evidenzübersichten, die nach Entwicklung von PICO-(Patients/Interventions/Control/Outcome-)Fragen, systematischer Recherche in Literaturdatenbanken sowie Selektion und Bewertung der gefundenen Literatur angefertigt wurden. In den interdisziplinären Arbeitsgruppen wurden auf dieser Grundlage Vorschläge für Empfehlungen und Statements erarbeitet, die im Rahmen von strukturierten Konsensusverfahren modifiziert und graduiert wurden.
Empfehlungen: Der Teil 1 dieser Kurzversion der Leitlinie zeigt Empfehlungen zur Früherkennung, Diagnostik und Nachsorge des Mammakarzinoms: Der Stellenwert des Mammografie-Screenings wird in der aktualisierten Leitlinienversion bestätigt und bildet damit die Grundlage der Früherkennung. Neben den konventionellen Methoden der Karzinomdiagnostik wird die Computertomografie (CT) zum Staging bei höherem Rückfallrisiko empfohlen. Die Nachsorgekonzepte beinhalten Untersuchungsintervalle für die körperliche Untersuchung, Ultraschall und Mammografie, während weiterführende Gerätediagnostik und Tumormarkerbestimmungen bei der metastasierten Erkrankung Anwendung finden.